$EHVVF Cashflow Statement | Understand Stock

$EHVVF

$0.00 +$0.00 (0.0%) Close

$EHVVF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	Year to Dec 2024 12 months to Dec 31, 2024	Year to Dec 2023 12 months to Dec 31, 2023	Year to Dec 2022 12 months to Dec 31, 2022	Year to Dec 2021 12 months to Dec 31, 2021	Year to Dec 2019 12 months to Dec 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Loss from discontinued operations
Loss from continuing operations
Net loss from operations
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense
Amortization expense
Gain recognized on common stock issued to settle liability
Stock-based compensation
Amortization of debt discount
Equity payable to Chief Executive Officer recorded as operating expense
Non-cash interest expense
Impairment of fixed assets
Loss (gain) on settlement of debt
Impairment of investments
Gain on settlement of debt
Changes in operating assets and liabilities:
Other receivables
Prepaid expenses and other assets
Accounts payable and accrued expenses
Accrued interest on convertible notes
Refundable taxes receivable

NET CASH USED IN OPERATING ACTIVITIES - CONTINUING OPERATIONS
NET CASH USED IN OPERATING ACTIVITIES - DISCONTINUED OPERATIONS
Accrued interest on convertible notes
Accrued expenses - related party

NET CASH USED IN OPERATING ACTIVITIES

NET CASH PROVIDED BY INVESTING ACTIVITIES - CONTINUING OPERATIONS
NET CASH PROVIDED BY INVESTING ACTIVITIES - DISCONTINUED OPERATIONS
Proceeds from sale of subsidiary
Purchase of subsidiary
Purchase of fixed assets
Proceeds from promissory notes
Proceeds from the issuance of preferred stock
Proceeds from convertible notes
Payment of promissory notes
NET CASH PROVIDED BY FINANCING ACTIVITIES - CONTINUING OPERATIONS
Proceeds from Reg A investment
NET CASH PROVIDED BY FINANCING ACTIVITIES
Effect of exchange rate on cash
Net decrease in cash
Cash, beginning of year
Cash, end of year
NON-CASH INVESTING AND FINANCING ACTIVITIES
Common stock issued for conversion of debt
Common stock issued to settle accounts payable and accrued expenses
Issuance of Preferred Series B
Common stock issued for conversion of accounts payable
Common stock issued for conversion of accounts payable and accrued expenses
Conversion of Mycotopia preferred stock into Mycotopia common stock
Debt discount on convertible notes payable
Conversion of convertible debt and interest into Mycotopia common stock
Common stock issued for purchase of Ketadash, prior to impairment

SUPPLEMENTAL CASH FLOW INFORMATION:
Accrued Interest converted to common
Debt converted to common stock

Comments